Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cancer|March 1, 2023
The role of ubiquitin pathway-mediated regulation of immune checkpoints in cancer immunotherapyXiaoming Zhou, Chengxiao Fu, Xisha Chen
Biochemical and Biophysical Research Communications|November 3, 2024
ZBTB7A as a therapeutic target for cancerYing Zhou, Xisha Chen, Xuyu Zu
Biomaterials Science|April 7, 2025
A light-activated Fe2+ release nanosystem for enhanced chemodynamic/chemo therapy via cascade amplification of ROS generationWei Guo, Min Wang, Xisha Chen, et al.
NPJ Breast Cancer|May 28, 2024
Overexpression of COL11A1 confers tamoxifen resistance in breast cancerChengxiao Fu, Shan Duan, Xiaoming Zhou, et al.
Chinese Medicine|July 16, 2025
The emerging role of mitochondria in the pharmacological and toxicological effects of Tripterygium wilfordii Hook F: functions, targets and new therapeutic applicationsZhonghao Liu, Dan Li, Xiongwen Yang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 25, 2021
Emerging role of autophagy in anti-tumor immunity: Implications for the modulation of immunotherapy resistanceTing Jiang, Xisha Chen, Xingcong Ren, et al.
Pharmacological Research|November 24, 2025
Pleiotropic effects of SGLT2 inhibitors: A focus on macrophage-mediated actionBing Shu, Xisha Chen, Zhonghao Liu, et al.
Molecular Medicine (Cambridge, Mass.)|April 23, 2025
Warburg effect and lactylation in cancer: mechanisms for chemoresistanceWenjie Zhang, Min Xia, Jiahui Li, et al.
Chemico-Biological Interactions|November 23, 2021
CHMFL-BMX-078, a BMX inhibitor, overcomes the resistance of melanoma to vemurafenib via inhibiting AKT pathwayShiLong Jiang, Ting Jiang, HanXue Huang, et al.
Cell Death & Disease|February 25, 2026
Deubiquitinase UCH-L1 confers paclitaxel resistance via stabilizing PKM2 to promote glycolysis in triple-negative breast cancerXisha Chen, Xiaoming Zhou, Yingcai Meng, et al.
Pageof 2